EDP Sciences logo
Subscriber Authentication Point
rechercher
Menu
Accueil Tous les numéros Therapie, 69 5 (2014) 395-400 Article's citations

Articles citing this article

The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).

Cited article:

Adverse drug reaction reporting with the Med Safety app in Uganda: a cluster-randomised, controlled trial

Ronald Kiguba, Helen B Ndagije, Norah Mwebaza, Ronald Ssenyonga, Lilian Giibwa, Gerald Isabirye, Jonathan Owiny, Victoria Nambasa, Ismail Ntale, Joanitah Atuhaire, Douglas Mwesigwa, Julius Mayengo, David Walusimbi, Ian Mugisa, Cordelia Katureebe, Kendal Harrison, Charles Karamagi and Munir Pirmohamed
The Lancet Global Health 13 (10) e1761 (2025)
https://doi.org/10.1016/S2214-109X(25)00299-2

Evaluation of a self-screening tool and patient alert cards to help patients identify and manage severe adverse drug reactions

Warisara Srisuriyachanchai, Chingching Foocharoen, Ajanee Mahakkanukrauh, Anthony R. Cox and Narumol Jarernsiripornkul
International Journal of Clinical Pharmacy 47 (3) 726 (2025)
https://doi.org/10.1007/s11096-025-01864-9

Effectiveness of the modified TaWai mobile application for reporting adverse drug reaction in Lao PDR: a cluster randomized controlled trial

Niphonh Mongkhonmath, Phayom Sookaneknun Olson, Panupong Puttarak, Soulyvanh Keokinnaly and Ratree Sawangjit
Scientific Reports 14 (1) (2024)
https://doi.org/10.1038/s41598-024-82474-9

Evaluation of a simplified pharmacovigilance tool for general practitioners: 5 years of insight

A. Trenque, A. Rabiaza, S. Fedrizzi, B. Chretien, M. Sassier, R. Morello, J. Alexandre and X. Humbert
Scientific Reports 14 (1) (2024)
https://doi.org/10.1038/s41598-024-51753-w

Factors Associated with Underreporting of Adverse Drug Reactions by Health Care Professionals: A Systematic Review Update

Patricia García-Abeijon, Catarina Costa, Margarita Taracido, Maria Teresa Herdeiro, Carla Torre and Adolfo Figueiras
Drug Safety 46 (7) 625 (2023)
https://doi.org/10.1007/s40264-023-01302-7

Cabinets de médecine générale et notification des effets indésirables médicamenteux : expertise d’un délégué de l’Assurance maladie

Sophie Fedrizzi, Basile Chrétien, Marion Sassier, Philippe Decaen, Mehedi Paul, Joachim Alexandre and Xavier Humbert
Santé Publique Vol. 34 (6) 795 (2023)
https://doi.org/10.3917/spub.226.0795

A new paradigm in adverse drug reaction reporting: consolidating the evidence for an intervention to improve reporting

Raymond Li, Kate Curtis, Syed Tabish Zaidi, Connie Van and Ronald Castelino
Expert Opinion on Drug Safety 21 (9) 1193 (2022)
https://doi.org/10.1080/14740338.2022.2118712

Public-private partnership (3Ps) in ensuring safe use of medicines: An Indian experience

Vivekanandan Kalaiselvan, Shatrunajay Shukla, Shubhang Arora, Tarani Prakash Shrivastava and Rajeev Singh Raghuvanshi
Frontiers in Public Health 10 (2022)
https://doi.org/10.3389/fpubh.2022.930696

Effectiveness of the Med Safety mobile application in improving adverse drug reaction reporting by healthcare professionals in Uganda: a protocol for a pragmatic cluster-randomised controlled trial

Ronald Kiguba, Norah Mwebaza, Ronald Ssenyonga, Helen Byomire Ndagije, Victoria Nambasa, Cordelia Katureebe, Kenneth Katumba, Phil Tregunno, Kendal Harrison, Charles Karamagi, Kathryn A Scott and Munir Pirmohamed
BMJ Open 12 (7) e061725 (2022)
https://doi.org/10.1136/bmjopen-2022-061725

Assessment of Knowledge, Attitude and Practice of Adverse Drug Reaction Reporting Among Healthcare Professionals working in Primary, Secondary and Tertiary Healthcare Facilities in Ekiti State, South-West Nigeria

Theophilus A. Adegbuyi, Joseph O. Fadare, Ebisola J. Araromi, Abayomi O. Sijuade, Iyanu Bankole, Ilesanmi K. Fasuba and Rachel A. Alabi
Hospital Pharmacy 56 (6) 751 (2021)
https://doi.org/10.1177/0018578720957968

Effectiveness of interventions to improve adverse drug reaction reporting by healthcare professionals over the last decade: A systematic review

Raymond Li, Syed Tabish Razi Zaidi, Timothy Chen and Ronald Castelino
Pharmacoepidemiology and Drug Safety 29 (1) 1 (2020)
https://doi.org/10.1002/pds.4906

Interventions to improve adverse drug reaction reporting: A scoping review

Malahat Khalili, Bita Mesgarpour, Hamid Sharifi, Samira Daneshvar Dehnavi and Ali Akbar Haghdoost
Pharmacoepidemiology and Drug Safety 29 (9) 965 (2020)
https://doi.org/10.1002/pds.4966

Reporting of adverse drug reactions in India: A review of the current scenario, obstacles and possible solutions

Rubina Mulchandani and Ashish Kumar Kakkar
International Journal of Risk & Safety in Medicine 30 (1) 33 (2019)
https://doi.org/10.3233/JRS-180025

L’activité de recueil des centres régionaux de pharmacovigilance est-elle influée par des déterminants régionaux démographiques ou sanitaires ?

Laurent Lam, Christelle Desitter and Patrick Maison
Therapies 74 (3) 333 (2019)
https://doi.org/10.1016/j.therap.2018.05.002

Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon

Aline Hajj, Souheil Hallit, Elsy Ramia and Pascale Salameh
Current Medical Research and Opinion 34 (1) 149 (2018)
https://doi.org/10.1080/03007995.2017.1361916

Adverse Drug Reaction Reports Received Through the Mobile App, VigiBIP®: A Comparison with Classical Methods of Reporting

François Montastruc, Haleh Bagheri, Isabelle Lacroix, et al.
Drug Safety 41 (5) 511 (2018)
https://doi.org/10.1007/s40264-017-0630-2

Barriers to the success of an electronic pharmacovigilance reporting system in Kenya: an evaluation three years post implementation

Oscar O Agoro, Sarah W Kibira, Jenny V Freeman and Hamish S F Fraser
Journal of the American Medical Informatics Association 25 (6) 627 (2018)
https://doi.org/10.1093/jamia/ocx102

Apport de la visite d’assistants de recherche clinique aux cabinets de médecins généralistes sur la notification des effets indésirables médicamenteux

Geneviève Durrieu, Julien Jacquot, Dominique Baudrin, et al.
Therapies 72 (3) 351 (2017)
https://doi.org/10.1016/j.therap.2016.09.004

Patient Participation and the Use of Ehealth Tools for Pharmacoviligance

Joëlle Berrewaerts, Laure Delbecque, Pierre Orban and Martin Desseilles
Frontiers in Pharmacology 7 (2016)
https://doi.org/10.3389/fphar.2016.00090

How to promote adverse drug reaction reports using information systems – a systematic review and meta-analysis

Inês Ribeiro-Vaz, Ana-Marta Silva, Cristina Costa Santos and Ricardo Cruz-Correia
BMC Medical Informatics and Decision Making 16 (1) (2016)
https://doi.org/10.1186/s12911-016-0265-8

L’apport de la pharmaco-épidémiologie à la pharmacovigilance

Jean-Luc Faillie, François Montastruc, Jean-Louis Montastruc and Antoine Pariente
Therapies 71 (2) 203 (2016)
https://doi.org/10.1016/j.therap.2016.02.015

Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study

Geneviève Durrieu, Julien Jacquot, Mathilde Mège, et al.
Drug Safety 39 (12) 1189 (2016)
https://doi.org/10.1007/s40264-016-0463-4

Bisphosphonate‐related osteonecrosis of the jaw: data from the French national pharmacovigilance database

Paul de Boissieu, Louise Gaboriau, Aurore Morel and Thierry Trenque
Fundamental & Clinical Pharmacology 30 (5) 450 (2016)
https://doi.org/10.1111/fcp.12211